Scotia Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$75.7M Buy
873,375
+5,341
+0.6% +$512K 0.31% 60
2025
Q4
$83.4M Sell
868,034
-74,307
-8% -$7.22M 0.34% 58
2025
Q3
$89.8M Buy
942,341
+15,894
+2% +$1.46M 0.38% 51
2025
Q2
$80.8M Sell
926,447
-48,814
-5% -$4.14M 0.38% 50
2025
Q1
$87.6M Sell
975,261
-75,669
-7% -$6.77M 0.47% 45
2024
Q4
$84M Sell
1,050,930
-3,033
-0.3% -$263K 0.44% 49
2024
Q3
$94.9M Sell
1,053,963
-9,156
-0.9% -$770K 0.51% 41
2024
Q2
$83.7M Buy
1,063,119
+68,452
+7% +$5.61M 0.49% 43
2024
Q1
$86.7M Buy
994,667
+213,705
+27% +$18.2M 0.52% 40
2023
Q4
$64.3M Sell
780,962
-20,680
-3% -$1.58M 0.41% 46
2023
Q3
$62.8M Buy
801,642
+18,239
+2% +$1.53M 0.45% 45
2023
Q2
$69M Buy
783,403
+6,307
+0.8% +$543K 0.47% 43
2023
Q1
$62.7M Buy
777,096
+251,180
+48% +$20.5M 0.46% 44
2022
Q4
$40.9M Sell
525,916
-130,381
-20% -$10.6M 0.31% 56
2022
Q3
$53M Sell
656,297
-28,787
-4% -$2.59M 0.43% 43
2022
Q2
$61.5M Buy
685,084
+12,683
+2% +$1.29M 0.46% 45
2022
Q1
$74.6M Buy
672,401
+143,060
+27% +$15.1M 0.47% 46
2021
Q4
$54.8M Buy
529,341
+45,442
+9% +$5.26M 0.36% 55
2021
Q3
$60.7M Buy
483,899
+18,676
+4% +$2.42M 0.44% 47
2021
Q2
$57.7M Buy
465,223
+16,555
+4% +$2.08M 0.42% 49
2021
Q1
$53M Buy
448,668
+21,658
+5% +$2.54M 0.43% 51
2020
Q4
$50M Buy
427,010
+10,314
+2% +$1.14M 0.46% 48
2020
Q3
$43.3M Buy
416,696
+16,831
+4% +$1.69M 0.47% 48
2020
Q2
$36.7M Buy
399,865
+112,991
+39% +$10.8M 0.51% 43
2020
Q1
$25.9M Buy
286,874
+20,900
+8% +$2.22M 0.36% 61
2019
Q4
$30.2M Buy
265,974
+6,295
+2% +$691K 0.34% 63
2019
Q3
$28.2M Buy
259,679
+26,145
+11% +$2.73M 0.33% 63
2019
Q2
$22.7M Buy
233,534
+26,979
+13% +$2.46M 0.28% 66
2019
Q1
$18.8M Buy
206,555
+96,801
+88% +$8.66M 0.24% 72
2018
Q4
$9.98M Sell
109,754
-398
-0.4% -$37.2K 0.15% 94
2018
Q3
$10.8M Sell
110,152
-18,968
-15% -$1.75M 0.14% 97
2018
Q2
$10.3M Buy
129,120
+1,587
+1% +$133K 0.14% 99
2018
Q1
$10.2M Buy
127,533
+16,798
+15% +$1.39M 0.14% 101
2017
Q4
$8.94M Buy
110,735
+21,318
+24% +$1.71M 0.12% 115
2017
Q3
$6.95M Buy
89,417
+12,804
+17% +$1.06M 0.1% 130
2017
Q2
$6.8M Buy
76,613
+1,910
+3% +$161K 0.11% 121
2017
Q1
$6.02M Buy
74,703
+163
+0.2% +$12.7K 0.1% 131
2016
Q4
$5.31M Buy
74,540
+19,395
+35% +$1.52M 0.08% 160
2016
Q3
$4.75M Buy
55,145
+7,592
+16% +$662K 0.09% 163
2016
Q2
$4.13M Sell
47,553
-9,129
-16% -$738K 0.08% 160
2016
Q1
$4.25M Buy
56,682
+4,546
+9% +$342K 0.09% 135
2015
Q4
$4.01M Buy
52,136
+900
+2% +$67.7K 0.09% 172
2015
Q3
$3.43M Sell
51,236
-2,401
-4% -$177K 0.08% 187
2015
Q2
$3.93M Buy
53,637
+5,837
+12% +$446K 0.08% 175
2015
Q1
$3.73M Buy
47,800
+1,998
+4% +$151K 0.1% 147
2014
Q4
$3.31M Sell
45,802
-307
-0.7% -$21.3K 0.09% 148
2014
Q3
$2.85M Buy
46,109
+118
+0.3% +$7.5K 0.06% 175
2014
Q2
$2.93M Buy
45,991
+8,655
+23% +$526K 0.06% 163
2014
Q1
$2.3M Buy
37,336
+2,740
+8% +$160K 0.05% 184
2013
Q4
$1.99M Buy
34,596
+4,166
+14% +$236K 0.05% 191
2013
Q3
$1.62M Sell
30,430
-767
-2% -$41.3K 0.04% 200
2013
Q2
$1.61M Buy
+31,197
New +$1.54M 0.06% 176

Other funds holding MDT

Scotia Capital's MDT Position: Q1 2026 in Review

Scotia Capital increased its Medtronic (MDT) stake by 0.62% in Q1 2026, buying an estimated $512K and bringing the position to 873,375 shares worth $75.7M. The position accounts for 0.31% of the portfolio, ranked #60.

Scotia Capital first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $94.9M in Q3 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Scotia Capital held 873,375 shares of Medtronic worth $75.7M as of Q1 2026.
  • Scotia Capital bought 5,341 Medtronic shares in Q1 2026, an estimated $512K.
  • Medtronic made up 0.31% of Scotia Capital's portfolio in Q1 2026, its #60 holding.
  • Scotia Capital first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Scotia Capital's Medtronic position peaked at $94.9M in Q3 2024.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Scotia Capital's 13F filing for Q1 2026, filed 13 May 2026.